This will be a game changer. There are more than 2 PML cases. They are still being investigated. Now Tysabri, Gilenya, and Tecfidera all have PML patients in only 4 years. Back to injectables!
I would love to make a bet with you on who will be leading market trend by the year end. You cannot go by current data because Teva (market leader) switched everyone to 40 MG. My guess is your a novartian that was laid off by novartis and then brought back to the MSBU because they know you were too stupid to know that you are making 30k less than other MS reps. Go work on your rocket plans and think of reasons why you should hold a conferance call.